Global Next Generation Diabetes Therapy and Drug Delivery Market Research Report 2024(Status and Outlook)

Global Next Generation Diabetes Therapy and Drug Delivery Market Research Report 2024(Status and Outlook)



Report Overview:

Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.

The Global Next Generation Diabetes Therapy and Drug Delivery Market Size was estimated at USD 2239.56 million in 2023 and is projected to reach USD 7869.39 million by 2029, exhibiting a CAGR of 23.30% during the forecast period.

This report provides a deep insight into the global Next Generation Diabetes Therapy and Drug Delivery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Next Generation Diabetes Therapy and Drug Delivery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Next Generation Diabetes Therapy and Drug Delivery market in any manner.

Global Next Generation Diabetes Therapy and Drug Delivery Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Johnson & Johnson

Abbott Laboratories

Medtronic

Sanofi

Novo Nordisk

MannKind Corporation

Enteris BioPharma

Dexcom

Senseonics

Medtech

Synertech

Zosano Pharma

Relmada Therapeutics

Eli Lilly and Company

Transdermal Specialties

Market Segmentation (by Type)

Inhalable Insulin

Oral Insulin

Insulin Patches

CGM Systems

Artificial Pancreas

Market Segmentation (by Application)

Diagnostic/Clinics

ICUs

Home Healthcare

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Next Generation Diabetes Therapy and Drug Delivery Market
  • Overview of the regional outlook of the Next Generation Diabetes Therapy and Drug Delivery Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Next Generation Diabetes Therapy and Drug Delivery Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Next Generation Diabetes Therapy and Drug Delivery
1.2 Key Market Segments
1.2.1 Next Generation Diabetes Therapy and Drug Delivery Segment by Type
1.2.2 Next Generation Diabetes Therapy and Drug Delivery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Next Generation Diabetes Therapy and Drug Delivery Market Overview
2.1 Global Market Overview
2.1.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Next Generation Diabetes Therapy and Drug Delivery Market Competitive Landscape
3.1 Global Next Generation Diabetes Therapy and Drug Delivery Sales by Manufacturers (2019-2024)
3.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
3.3 Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Next Generation Diabetes Therapy and Drug Delivery Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Next Generation Diabetes Therapy and Drug Delivery Sales Sites, Area Served, Product Type
3.6 Next Generation Diabetes Therapy and Drug Delivery Market Competitive Situation and Trends
3.6.1 Next Generation Diabetes Therapy and Drug Delivery Market Concentration Rate
3.6.2 Global 5 and 10 Largest Next Generation Diabetes Therapy and Drug Delivery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Next Generation Diabetes Therapy and Drug Delivery Industry Chain Analysis
4.1 Next Generation Diabetes Therapy and Drug Delivery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Next Generation Diabetes Therapy and Drug Delivery Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Next Generation Diabetes Therapy and Drug Delivery Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Type (2019-2024)
6.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Type (2019-2024)
6.4 Global Next Generation Diabetes Therapy and Drug Delivery Price by Type (2019-2024)
7 Next Generation Diabetes Therapy and Drug Delivery Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Sales by Application (2019-2024)
7.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (M USD) by Application (2019-2024)
7.4 Global Next Generation Diabetes Therapy and Drug Delivery Sales Growth Rate by Application (2019-2024)
8 Next Generation Diabetes Therapy and Drug Delivery Market Segmentation by Region
8.1 Global Next Generation Diabetes Therapy and Drug Delivery Sales by Region
8.1.1 Global Next Generation Diabetes Therapy and Drug Delivery Sales by Region
8.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Region
8.2 North America
8.2.1 North America Next Generation Diabetes Therapy and Drug Delivery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Next Generation Diabetes Therapy and Drug Delivery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Next Generation Diabetes Therapy and Drug Delivery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Johnson and Johnson
9.1.1 Johnson and Johnson Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.1.2 Johnson and Johnson Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.1.3 Johnson and Johnson Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.1.4 Johnson and Johnson Business Overview
9.1.5 Johnson and Johnson Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
9.1.6 Johnson and Johnson Recent Developments
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.2.2 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.2.4 Abbott Laboratories Business Overview
9.2.5 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
9.2.6 Abbott Laboratories Recent Developments
9.3 Medtronic
9.3.1 Medtronic Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.3.2 Medtronic Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.3.4 Medtronic Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
9.3.5 Medtronic Business Overview
9.3.6 Medtronic Recent Developments
9.4 Sanofi
9.4.1 Sanofi Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.4.2 Sanofi Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Recent Developments
9.5 Novo Nordisk
9.5.1 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.5.2 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.5.4 Novo Nordisk Business Overview
9.5.5 Novo Nordisk Recent Developments
9.6 MannKind Corporation
9.6.1 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.6.2 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.6.4 MannKind Corporation Business Overview
9.6.5 MannKind Corporation Recent Developments
9.7 Enteris BioPharma
9.7.1 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.7.2 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.7.4 Enteris BioPharma Business Overview
9.7.5 Enteris BioPharma Recent Developments
9.8 Dexcom
9.8.1 Dexcom Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.8.2 Dexcom Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.8.4 Dexcom Business Overview
9.8.5 Dexcom Recent Developments
9.9 Senseonics
9.9.1 Senseonics Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.9.2 Senseonics Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.9.4 Senseonics Business Overview
9.9.5 Senseonics Recent Developments
9.10 Medtech
9.10.1 Medtech Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.10.2 Medtech Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.10.4 Medtech Business Overview
9.10.5 Medtech Recent Developments
9.11 Synertech
9.11.1 Synertech Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.11.2 Synertech Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.11.4 Synertech Business Overview
9.11.5 Synertech Recent Developments
9.12 Zosano Pharma
9.12.1 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.12.2 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.12.4 Zosano Pharma Business Overview
9.12.5 Zosano Pharma Recent Developments
9.13 Relmada Therapeutics
9.13.1 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.13.2 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.13.4 Relmada Therapeutics Business Overview
9.13.5 Relmada Therapeutics Recent Developments
9.14 Eli Lilly and Company
9.14.1 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.14.2 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.14.4 Eli Lilly and Company Business Overview
9.14.5 Eli Lilly and Company Recent Developments
9.15 Transdermal Specialties
9.15.1 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.15.2 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.15.4 Transdermal Specialties Business Overview
9.15.5 Transdermal Specialties Recent Developments
10 Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Region
10.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast
10.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast by Country
10.2.3 Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast by Region
10.2.4 South America Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Next Generation Diabetes Therapy and Drug Delivery by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Next Generation Diabetes Therapy and Drug Delivery by Type (2025-2030)
11.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Next Generation Diabetes Therapy and Drug Delivery by Type (2025-2030)
11.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Application (2025-2030)
11.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) Forecast by Application
11.2.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings